Dishman Carbogen Amcis Limited share price

Dishman Carbogen Amcis Limited provides contract development and manufacturing organization (CDMO) services for the pharmaceutical and healthcare industries worldwide. It operates through Integrated CDMO Platform and Marketable Molecules segments. The company offers cholesterol and vitamin D analogs; soft gel capsules and formulations; intermediate and active pharmaceutical ingredients (APIs) which cover specific therapeutic areas, such as anesthetics, and contrast media agents for diagnostics, ophthalmic treatments, laxatives, and organophosphate antidotes; ammonium and phosphonium; quats, phosphoranes, and wittig reagents; generic intermediates; cholesterol and lanolin-related products; s…Read more

Website NSE BSE

HealthcareBiotechnologyNSE: DCALISIN INE385W01011

16 Oct 2026, 3:29 PM IST₹149.83▼ 1.35 (0.89%)

Market Cap₹ 2,349 Cr.
Current Price₹ 149.83
High / Low₹ 303 / 129
Stock P/E146.9
Book Value₹ 427
Dividend Yield0.00 %
ROCE2.7 %
ROE1.60 %
Face Value₹ 2.0

More figures (10)

EPS (TTM)₹ 1.02
Price / Book0.35
OPM6.9 %
Debt / Equity0.46
Sales growth (5Y)8.9 %
Profit growth (5Y)—
Promoter holding69.3 %
EV / EBITDA8.8
Beta0.65
All-time high₹ 396

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
DCAL	-7.56%	-22.81%	-12.13%	-39.48%	-47.77%	-2.49%	-8.21%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Dishman Carbogen Amcis Limited is in the Biotechnology industry (Healthcare), with a market value of ₹2,349 crore.
It trades at 146.9 times its last 12 months' earnings and 0.4 times book value.
Revenue grew 8.9% a year over the last 5 years.
Return on equity was 1.6% and return on capital employed 2.7% in the latest year.
Debt was 0.46 times shareholders' equity.
The share price is 50.6% below its 52-week high and down 47.8% over one year.
Promoters and insiders hold about 69.3%; institutions about 2.7%.

Pros

No standout strengths in the reported figures.

Cons

Return on equity has been low: -0.3% on average over the last 3 years.
Interest cover is thin: operating earnings are 1.1 times the interest cost.
Latest quarter (Jun 2026): profit fell 347% from a year ago.
Other income makes up 329% of profit before tax.
Trades at 146.9 times earnings, above its 3-year median of 34.1.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Dishman Carbogen Amcis Limited

Employees: 934
Head office: Ahmedabad

HealthcareBiotechnology

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Dishman Carbogen Amcis	149.83	146.9	2,349	-58	-347.24	678	-4.29	2.7	1.6	0.35	6.9	0.46	69.30	2,932	8.9
2.	OneSource Specialty Pharma	1,407.80	—	16,144	25	—	449	37.20	0.3	-1.3	2.77	-0.4	0.26	35.49	1,422	232.4
	Median: 2 Co.	778.82	146.9	9,246	-16	-347.24	563	16.45	1.5	0.2	1.56	3.3	0.36	52.40	2,177	120.7

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	723	587	651	655	524	789	682	716	708	653	720	851	678
YOY Sales Growth %	33.81%	-4.46%	1.77%	5.84%	-27.59%	34.51%	4.80%	9.41%	35.18%	-17.29%	5.49%	18.85%	-4.29%
	602	526	610	592	495	642	542	564	567	504	607	688	618
Material Cost %	23%	23%	18%	28%	13%	24%	14%	20%	14%	5%	20%	16%	17%
Employee Cost %	41%	48%	47%	49%	60%	41%	49%	45%	50%	51%	49%	48%	57%
Other Expenses %	20%	18%	28%	14%	21%	17%	16%	13%	17%	21%	15%	17%	17%
Operating Profit	122	61	41	63	29	147	140	153	141	149	113	163	60
OPM %	17%	10%	6%	10%	6%	19%	21%	21%	20%	23%	16%	19%	9%
	7	8	6	7	1	7	6	8	25	8	7	16	18
Exceptional items		-3		-3	-5	-3	2	-12	-3			-1	-2
Interest	28	27	33	31	32	37	49	42	43	42	46	43	37
Depreciation	70	75	80	85	71	72	72	79	81	84	84	89	91
Profit before tax	29	-36	-66	-49	-78	42	27	28	39	31	-10	46	-51
	42%					21%	83%	-56%	39%	-114%		53%
Current tax	20	7	1	26	1	21	27	-5	19	3	11	26	3
Deferred tax	-7	-3	-7	-6	-1	-12	-4	-11	-3	-38	-9	-1	3
	17	-41	-60	-70	-78	33	5	43	23	65	-13	22	-58
Profit to shareholders		-41	-60	-70	-78	33	5	43	23	65	-13	22	-58
YOY Profit Growth %	323.94%		-226.98%		-556.29%					97.25%	-380.13%	-49.55%	-347.24%
EPS in Rs	1.08	-2.61	-3.80	-4.46	-4.95	2.11	0.30	2.75	1.49	4.16	-0.83	1.39	-3.69
Raw filing

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	70	60	87	111	103	93	97	106	63	60	40	69	57
YOY Sales Growth %	-32.87%	-43.95%	10.74%	-1.65%	48.68%	56.21%	11.77%	-4.64%	-39.21%	-35.36%	-59.11%	-35.23%	-9.20%
	75	63	84	100	89	80	74	86	59	56	43	68	69
Material Cost %	39%	10%	49%	36%	40%	34%	26%	31%	18%	20%	-3%	25%	24%
Employee Cost %	32%	38%	27%	21%	22%	24%	24%	20%	35%	36%	54%	31%	37%
Other Expenses %	37%	57%	20%	32%	23%	27%	27%	30%	41%	36%	58%	43%	60%
Operating Profit	-5	-3	3	12	15	13	23	21	3	4	-4	1	-12
OPM %	-7%	-5%	4%	10%	14%	14%	24%	19%	5%	7%	-9%	1%	-21%
	14	39	13	-3	12	24	-8	5	37	11	7	29	19
Exceptional items		-3											-2
Interest	18	17	17	16	16	16	18	21	20	21	24	22	22
Depreciation	25	25	26	26	16	16	16	16	16	16	15	15	15
Profit before tax	-33	-9	-27	-34	-6	5	-19	-11	4	-21	-35	-7	-32
						-162%			35%
Deferred tax	-12	-3	-9	-3	-2	-9	-6	-4	1	-7	-12	-3	-8
	-21	-6	-18	-31	-3	14	-13	-7	3	-14	-23	-4	-24
YOY Profit Growth %										-195.44%			-995.51%
EPS in Rs	-1.36	-0.37	-1.16	-1.98	-0.22	0.91	-0.85	-0.47	0.17	-0.87	-1.47	-0.28	-1.52
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	1,695	1,695	2,059	2,044	1,912	2,141	2,413	2,616	2,712	2,932	2,901
YOY Sales Growth %			21.47%	-0.73%	-6.44%	11.96%	12.72%	8.41%	3.66%	8.13%
	1,249	1,249	1,507	1,521	1,638	1,809	2,081	2,329	2,243	2,366	2,416
Material Cost %	20%	20%	20%	21%	24%	21%	21%	23%	19%	14%	15%
Employee Cost %	37%	37%	35%	37%	46%	46%	43%	46%	48%	49%	51%
Other Expenses %	17%	17%	19%	16%	16%	18%	22%	20%	16%	17%	17%
Operating Profit	445	445	552	522	274	331	332	287	469	566	485
OPM %	26%	26%	27%	26%	14%	15%	14%	11%	17%	19%	17%
	46	46	54	44	38	43	28	28	22	56	49
Exceptional items					-22	-15	-48	-6	-18	-4	-3
Interest	49	49	57	62	48	57	86	120	159	174	169
Depreciation	211	211	240	283	308	308	281	311	294	339	348
Profit before tax	231	231	309	222	-65	-4	-55	-122	19	105	15
	33%	33%	32%	19%					83%	7%	-8%
Current tax	49	49	89	27	44	22	30	54	44	59
Deferred tax	28	28	9	15	56	-44	-55	-23	-28	-52
	155	155	210	180	-165	18	-30	-153	3	97	16
Profit to shareholders	155	155	210	180	-165	18	-30	-153	3	97	16
YOY Profit Growth %			36.07%	-14.28%	-191.59%		-265.46%			2,907.72%
EPS in Rs	9.58	9.58	13.03	11.20	-10.53	1.15	-1.90	-9.79	0.21	6.22	1.03

Compounded Sales Growth

5 Years:: 9%
3 Years:: 7%
TTM:: 0%

Compounded Profit Growth

TTM:: -84%

Stock Price CAGR

5 Years:: -8%
3 Years:: -2%
1 Year:: -48%

Return on Equity

4 Years:: 0%
Last Year:: 2%

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	474	474	549	581	208	303	403	327	400	232	226
YOY Sales Growth %			15.81%	5.69%	-64.18%	45.57%	32.95%	-18.68%	22.14%	-42.09%
	308	308	356	407	265	269	395	321	328	226	236
Material Cost %	33%	33%	30%	34%	52%	33%	43%	35%	33%	17%	18%
Employee Cost %	13%	13%	15%	15%	29%	27%	21%	28%	23%	37%	38%
Other Expenses %	19%	19%	21%	20%	47%	29%	34%	35%	27%	43%	48%
Operating Profit	166	166	194	174	-57	34	8	7	72	5	-10
OPM %	35%	35%	35%	30%	-28%	11%	2%	2%	18%	2%	-4%
	66	66	72	70	66	66	52	63	33	85	66
Exceptional items						-6	-2	-3			-2
Interest	35	35	47	47	34	37	58	68	70	87	88
Depreciation	134	134	136	141	143	140	96	102	65	63	61
Profit before tax	62	62	82	55	-169	-83	-96	-103	-31	-59	-95
	40%	40%	31%	31%
Current tax	8	8	17	9
Deferred tax	18	18	9	8	64	-53	-37	-27	-21	-21
	37	37	56	39	-233	-32	-59	-76	-10	-38	-65
YOY Profit Growth %			51.09%	-31.23%	-704.39%
EPS in Rs	2.30	2.30	3.47	2.46	-14.85	-2.01	-3.75	-4.87	-0.63	-2.45	-4.14

Compounded Sales Growth

5 Years:: 2%
3 Years:: -17%
TTM:: -37%

Stock Price CAGR

5 Years:: -8%
3 Years:: -2%
1 Year:: -48%

Return on Equity

4 Years:: 0%
Last Year:: 2%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	31	31	31	31
Reserves	5,778	5,596	5,800	6,646
	2,209	2,313	2,389	3,076
Long term borrowings	1,043	243	1,147	1,533
Short term borrowings	778	1,719	935	1,241
	1,435	1,641	1,779	2,170
Trade payables	220	244	258	254
Current liabilities	1,798	2,555	1,925	2,317
Total Liabilities	9,454	9,581	9,999	11,923
	3,235	3,236	3,200	3,562
Gross block	5,714	5,968	5,828	6,986
Accumulated depreciation	2,479	2,732	2,627	3,424
Goodwill & intangibles	3,999	4,134	4,346	5,198
CWIP	1,004	505	281	394
	5,215	5,840	6,518	7,967
Inventories	804	883	900	1,019
Trade receivables	590	484	665	673
Cash & equivalents	132	264	341	773
Current assets	1,918	1,928	2,200	2,842
Total Assets	9,454	9,581	9,999	11,923

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	266	379	371	491
Profit for the year	-30	-153	3	97
Working capital changes	-38	144	-85	-45
Direct taxes paid	-34	-19	-30	-5
	-494	-230	-192	-245
Fixed assets purchased	-620	-303	-217	-267
Fixed assets sold	1	0	1
Investments purchased	-12	-88	-25
Investments sold	121	150		12
	250	-22	-102	201
Proceeds from borrowings	332	148	283	681
Repayment of borrowings	-166	-98	-110	-376
Interest paid	-73	-99	-151	-156
Net Cash Flow	22	128	77	447
Free Cash Flow	-354	76	155	225

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	-0.5%	-2.7%	0.1%	1.6%
ROCE	—	0.3%	-0.1%	2.1%	2.7%
Operating margin	—	4.6%	-1.6%	5.5%	6.9%
Net margin	—	-1.3%	-6.0%	0.1%	3.4%
Debt / equity	—	0.38	0.41	0.41	0.46
Current ratio	—	1.07	0.75	1.14	1.23
Debtor days	—	93	70	92	85
Inventory days	—	549	527	625	875
Days payable	—	150	146	179	218
Cash conversion cycle	—	492	451	538	742
Working capital days	—	19	-90	38	67

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 59.32%
FIIs 6.86%
DIIs 2.07%
Public 31.75%

%	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	59.32%	59.32%	59.32%	59.32%	59.32%	59.32%	59.32%	59.32%	59.32%	59.32%	59.32%	59.32%
	8.80%	8.61%	8.70%	8.04%	8.17%	8.75%	9.49%	9.93%	8.07%	7.66%	7.45%	6.86%
Foreign portfolio investors (Cat. I)	5.02%	4.82%	4.91%	4.50%	4.63%	4.95%	4.98%	5.26%	5.26%	5.21%	4.92%	4.51%
Foreign portfolio investors (Cat. II)	3.78%	3.78%	3.79%	3.55%	3.55%	3.80%	4.51%	4.68%	2.81%	2.45%	2.53%	2.35%
	3.52%	3.69%	2.37%	1.47%	1.23%	1.42%	1.26%	1.27%	1.37%	1.27%	1.63%	2.07%
Mutual funds	3.28%	3.45%	2.17%	1.28%	1.03%	1.22%	1.06%	1.07%	1.08%	1.08%	1.06%	1.41%
Alternative investment funds	0.23%	0.23%	0.19%	0.19%	0.19%	0.19%	0.19%	0.19%	0.28%	0.18%	0.56%	0.64%
	28.36%	28.39%	29.61%	31.16%	31.28%	30.51%	29.93%	29.47%	31.23%	31.75%	31.60%	31.75%
Retail (up to ₹2 lakh)	15.96%	14.96%	14.76%	16.49%	16.93%	15.58%	14.74%	13.99%	14.11%	13.99%	14.33%	14.98%
HNIs (above ₹2 lakh)	8.68%	9.57%	10.41%	10.60%	10.50%	10.64%	10.57%	11.37%	12.73%	13.32%	12.87%	12.34%
NRIs	0.90%	0.88%	0.83%	0.82%	0.97%	0.91%	0.88%	0.89%	1.02%	1.00%	1.07%	1.07%
Bodies corporate	1.53%	1.75%	2.35%	1.91%	1.60%	1.66%	2.04%	1.72%	1.80%	1.73%	1.54%	1.53%
IEPF	0.01%	0.01%	0.01%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
No. of Shareholders	56,272	52,336	50,656	53,683	55,280	52,822	50,757	49,744	49,455	48,481	49,009	49,430

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Dishman Carbogen Amcis

Holder (above 1%)	Stake
HSBC Flexi Cap FundMutual fund	1.41%

As named in the shareholding pattern for Jun 2026 filed with NSE; mutual funds together hold 1.41% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 12 Sep 2019
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Dishman Carbogen Amcis Limited

What is the share price of Dishman Carbogen Amcis Limited today?

Dishman Carbogen Amcis Limited (DCAL) last traded at ₹149.83 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of Dishman Carbogen Amcis Limited?

About ₹2,349 crore at the latest price.

What is the P/E ratio of Dishman Carbogen Amcis Limited?

About 146.9 times its earnings over the last 12 months.

Is Dishman Carbogen Amcis Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Dishman Carbogen Amcis Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Dishman Carbogen Amcis Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Dishman Carbogen Amcis Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Mutual funds & institutions holding Dishman Carbogen Amcis

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about Dishman Carbogen Amcis Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next